Press Release

Funding will strengthen Qkine's executive leadership team, expand its presence in the US market, accelerate research and development, scale GMP and cell therapy-grade manufacturing capabilities, and enhance its digital platforms.

Distribution agreement gives U.S. customers a single-vendor source for high-quality cells, bioprocess media, and recombinant growth factors

Qkine to be a global distributor of Media City Scientific’s FRS™ Pioneer, a chemically-defined, animal replacement solution to support routine cell culture in traditional basal media.

Qkine will collaborate with fellow pioneers to establish the manufacturing standards and standardized frameworks necessary to accelerate the adoption of organoid technologies in drug discovery and clinical research.

Qkine now supplies Defined Bioscience’s animal-free cell culture supplements

In case you missed it, the 16th of December 2025 was a significant day in the US Senate, passing the […]

Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (iPSC)

BioLife will distribute certain cytokine and growth factor products manufactured by Qkine for use in cell and gene therapy manufacturing

Collaboration to Deliver High-Quality Cytokines and Growth Factors to Enable the Advancement of Stem Cell-Based Therapeutics

‍Qkine and Interlab based in Taipei, Taiwan, partner to distribute Qkine high purity growth factors and cytokines, empowering research in Taiwan.

At Qkine we have repeatedly highlighted the need for stricter process and quality control in the manufacture of high purity in recombinant growth factors to prevent cross contamination with related growth factors. Contamination with other bioactive proteins leads to lack of inter and intra-lab reproducibility, or perhaps most concerningly incorrect scientific conclusions.

From 1st September, Qkine will be introducing updated delivery options designed to give you more choice, flexibility and reward ongoing support.